Curis (CRIS) EBT Margin (QoQ) (2010 - 2025)
Curis (CRIS) EBT Margin (QoQ) (2010 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - |
| 10 | Curis | 3.35 Mn | -2.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 194,424.00 |
| Sep 30, 2025 | 6,923.00 |
| Jun 30, 2025 | 13,346.00 |
| Mar 31, 2025 | -14,336.00 |
| Dec 31, 2024 | 6,039.00 |
| Sep 30, 2024 | 11,653.00 |
| Jun 30, 2024 | 13,208.00 |
| Mar 31, 2024 | -18,974.00 |
| Dec 31, 2023 | 3,290.00 |
| Sep 30, 2023 | 12,699.00 |
| Jun 30, 2023 | -5,537.00 |
| Mar 31, 2023 | -16,686.00 |
| Dec 31, 2022 | 11,097.00 |
| Sep 30, 2022 | 20,664.00 |
| Jun 30, 2022 | 12,642.00 |
| Mar 31, 2022 | -36,412.00 |
| Dec 31, 2021 | -7,411.00 |
| Sep 30, 2021 | 14,989.00 |
| Jun 30, 2021 | -5,145.00 |
| Mar 31, 2021 | -38,080.00 |